Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In situ</i> growth of conductive bimetallic catecholate MOFs on porous graphene for high-performance formaldehyde gas sensing.

Nanoscale·2025
Same author

Characterization of novel Annona reticulata fiber as a potential reinforcement for composite applications.

Scientific reports·2025
Same author

Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes.

International journal of radiation oncology, biology, physics·2025
Same author

Machine Learning-Enhanced Chemiresistive Sensors for Ultra-Sensitive Detection of Methanol Adulteration in Alcoholic Beverages.

ACS sensors·2025
Same author

Harnessing mixed-phase MoS<sub>2</sub> for efficient room-temperature ammonia sensing.

Nanoscale·2024
Same author

A pilot program to improve TB care with primary and specialty care coordination in TB public health clinic.

IJTLD open·2024
Same journal

Delivery of TCM Monomers Using Blood Cell Membrane Coated Biomimetic Nanoparticles to Target CVD.

International journal of nanomedicine·2026
Same journal

Mechanism-Guided Nanoengineered Therapeutic Peptides for Bone Healing.

International journal of nanomedicine·2026
Same journal

MRI-Guided Magnetic Micro/Nanorobots for Precision Neurotherapeutics: From Intelligent Navigation and BBB Penetration to Clinical Translation.

International journal of nanomedicine·2026
Same journal

EGCG-Building Nanocarriers for Multitasking Drug Delivery: Design Principles, Therapeutic Opportunities, and Translational Challenges.

International journal of nanomedicine·2026
Same journal

Chitosan Oligosaccharide-Functionalized Ruthenium-Curcumin Nanodots for Targeted Therapy of Acute Kidney Injury.

International journal of nanomedicine·2026
Same journal

Magnetic Nanoparticles as a Theranostic Platform in Brain Tumor Treatment: Surmounting the Bench-to-Bedside Barriers.

International journal of nanomedicine·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Multi-access drug delivery network and stability.

S Mitatha1, N Moongfangklang, M A Jalil

  • 1Hybrid Computing Research Laboratory, Faculty of Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.

International Journal of Nanomedicine
|October 8, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a novel molecular network for precise drug delivery and diagnostics. Optical tweezers dynamically move drug molecules in a thin-film device for targeted patient treatment with minimal crosstalk.

Keywords:
drug delivery networkmolecular diagnosismolecular networksneural system and network

More Related Videos

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

Related Experiment Videos

Last Updated: May 28, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Networks

Background:

  • Current drug delivery systems lack precise targeting and integrated diagnostics.
  • Existing molecular networks are limited in dynamic control and miniaturization for patient use.

Purpose of the Study:

  • To propose a novel molecular network design for simultaneous multi-drug delivery and diagnosis.
  • To demonstrate dynamic control and targeted delivery of drug volumes using optical vortices.
  • To develop a miniaturized, embedded system suitable for patient diagnostics.

Main Methods:

  • Utilizing optical tweezers to generate intense optical vortices within a PANDA ring resonator.
  • Trapping and dynamically moving drug molecules within molecular bus networks.
  • Integrating various network topologies (ring, star, bus) for large-scale drug delivery systems.
  • Analyzing channel spacing and crosstalk effects within the molecular bus networks.

Main Results:

  • Successful dynamic trapping and movement of drug molecules within the molecular bus network.
  • Achieved targeted drug delivery to specific network locations.
  • Demonstrated the feasibility of a miniaturized, thin-film device for integrated drug delivery and diagnostics.
  • Quantified crosstalk effects to be approximately 0.1%, deemed negligible for network stability.

Conclusions:

  • The proposed molecular network offers a novel approach for precise, targeted drug delivery and integrated diagnostics.
  • The system's miniaturization and dynamic control capabilities make it suitable for embedded diagnostic devices in patients.
  • The integration of different network topologies allows for scalable and complex drug delivery systems.
  • The low crosstalk ensures the stability and reliability of the molecular drug delivery network.